IntriCon Co. (NASDAQ:IIN) – Research analysts at B. Riley decreased their Q2 2019 earnings estimates for shares of IntriCon in a research note issued on Tuesday, April 30th, Zacks Investment Research reports. B. Riley analyst A. D’silva now forecasts that the technology company will post earnings per share of $0.08 for the quarter, down from their prior forecast of $0.15. B. Riley also issued estimates for IntriCon’s Q3 2019 earnings at $0.21 EPS and Q4 2019 earnings at $0.25 EPS.
IntriCon (NASDAQ:IIN) last issued its quarterly earnings results on Monday, April 29th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by ($0.02). IntriCon had a net margin of 4.58% and a return on equity of 7.39%. The business had revenue of $30.11 million during the quarter, compared to the consensus estimate of $30.05 million.
Shares of IIN traded down $1.33 during midday trading on Wednesday, hitting $24.74. The company’s stock had a trading volume of 143,068 shares, compared to its average volume of 164,837. IntriCon has a one year low of $20.95 and a one year high of $76.80. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.03 and a current ratio of 3.13. The firm has a market cap of $222.88 million, a price-to-earnings ratio of 38.66, a PEG ratio of 3.39 and a beta of 1.15.
In related news, VP Greg Gruenhagen sold 1,500 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $25.33, for a total transaction of $37,995.00. Following the sale, the vice president now owns 4,047 shares in the company, valued at approximately $102,510.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 11.50% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Arbitrage SA bought a new stake in shares of IntriCon in the 1st quarter valued at about $40,000. MetLife Investment Advisors LLC acquired a new position in shares of IntriCon in the 3rd quarter valued at about $295,000. Sun Life Financial INC acquired a new position in shares of IntriCon in the 4th quarter valued at about $155,000. Rhumbline Advisers lifted its stake in shares of IntriCon by 58.9% in the 4th quarter. Rhumbline Advisers now owns 9,104 shares of the technology company’s stock valued at $240,000 after purchasing an additional 3,375 shares during the period. Finally, Conestoga Capital Advisors LLC acquired a new position in shares of IntriCon in the 1st quarter valued at about $235,000. Hedge funds and other institutional investors own 66.85% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Further Reading: What is diluted earnings per share (Diluted EPS)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.